ID

31997

Description

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin; ODM derived from: https://clinicaltrials.gov/show/NCT01119300 Sponsor: Utrecht Institute for Pharmaceutical Sciences Collaborators: Utrecht University Leiden University Medical Center Erasmus Medical Center University of Ulm Newcastle University University of Liverpool LGC Limited Uppsala University Democritus University of Thrace Elisabethinen Hospital Information provided by (Responsible Party): Anke-Hilse Maitland-van der Zee, Utrecht Institute for Pharmaceutical Sciences Principal Investigator: Munir Pirmohamed, MD PhD University of Liverpool

Lien

https://clinicaltrials.gov/show/NCT01119300

Mots-clés

Versions (1)
  1. 10/10/2018 10/10/2018 -
Détendeur de droits

Anke-Hilse Maitland-van der Zee, PharmD, PhD, Utrecht Institute for Pharmaceutical Sciences

Téléchargé le

10 octobre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Venous Thromboembolism Warfarin NCT01119300

Anglais

Eligibility Venous Thromboembolism Warfarin NCT01119300

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
Description

Venous thromboembolism or atrial fibrillation requiring coumarin therapy, target inr in the low intensity range

Type de données

boolean

Alias
UMLS CUI [1,1]
C1861172
UMLS CUI [1,2]
C0686904
UMLS CUI [1,3]
C0010206
UMLS CUI [2,1]
C0004238
UMLS CUI [2,2]
C0686904
UMLS CUI [2,3]
C0010206
UMLS CUI [3,1]
C1521840
UMLS CUI [3,2]
C0525032
age ≥ 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ability to attend scheduled visits
Description

Ability to attend scheduled visits

Type de données

boolean

Alias
UMLS CUI [1,1]
C2827364
UMLS CUI [1,2]
C0085732
signed informed consent
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of a mechanical heart valve
Description

Presence of a mechanical heart valve

Type de données

boolean

Alias
UMLS CUI [1]
C0493527
severe cognitive impairment
Description

Severe cognitive impairment

Type de données

boolean

Alias
UMLS CUI [1]
C3554639
known genotype cyp2c9 or vkorc1 at start of the study
Description

Known genotype cyp2c9 or vkorc1

Type de données

boolean

Alias
UMLS CUI [1]
C1332829
UMLS CUI [2]
C1428184
previous or current treatment with any coumarin
Description

Previous or current treatment with any coumarin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0010206
UMLS CUI [1,2]
C2827774
UMLS CUI [2,1]
C0010206
UMLS CUI [2,2]
C1514463
pregnancy or lactation
Description

Pregnancy or lactation

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0022925
non-eligible subject
Description

Ineligibility

Type de données

boolean

Alias
UMLS CUI [1]
C1512714
Retour au début de la page

Similar models

Eligibility Venous Thromboembolism Warfarin NCT01119300

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Venous thromboembolism or atrial fibrillation requiring coumarin therapy, target inr in the low intensity range
Item
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
boolean
C1861172 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0010206 (UMLS CUI [1,3])
C0004238 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0010206 (UMLS CUI [2,3])
C1521840 (UMLS CUI [3,1])
C0525032 (UMLS CUI [3,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Ability to attend scheduled visits
Item
ability to attend scheduled visits
boolean
C2827364 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Presence of a mechanical heart valve
Item
presence of a mechanical heart valve
boolean
C0493527 (UMLS CUI [1])
Severe cognitive impairment
Item
severe cognitive impairment
boolean
C3554639 (UMLS CUI [1])
Known genotype cyp2c9 or vkorc1
Item
known genotype cyp2c9 or vkorc1 at start of the study
boolean
C1332829 (UMLS CUI [1])
C1428184 (UMLS CUI [2])
Previous or current treatment with any coumarin
Item
previous or current treatment with any coumarin
boolean
C0010206 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0010206 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
Ineligibility
Item
non-eligible subject
boolean
C1512714 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial